Teva found liable for fueling opioid addiction in New York
Declining sales of blockbuster drug drag Teva revenue lower - MarketWatch
Teva, Texas Enter $225M Opioid Settlement Agreement
The wall street journal december 23 2016 by 24news - Issuu
Teva Pharmaceutical Is in Recovery - WSJ
Teva Pharmaceutical Industries Stock Jumps on a Rare Bullish View | Barron's
Israel's Teva rallies on modest settlement in opioid case - Business - Haaretz.com
Teva Poised to Get a Big Boost in Generics - WSJ
Calaméo - Wallstreetjournal 20160122 The Wall Street Journal
Darkest Before the Dawn at Teva - WSJ
Battered by a Tough Generics Market, Teva Pharma Emphasizes Biologics | BioSpace
Teva Pharmaceuticals - Wikipedia
Teva proposes $15 billion deal to settle opioid claims - The Jerusalem Post
Teva Pharmaceutical's Stock Tumbles on Outlook - WSJ
Teva Pharmaceutical to Nominate Four New Directors - WSJ
Teva Poised to Get a Big Boost in Generics - WSJ
Teva Pharmaceuticals - Wikipedia
Drug distributors and Teva reach settlement in Ohio opioid litigation: WSJ | Reuters
Teva Pharmaceuticals - Wikiwand
Now Comes the Hard Part at Teva - WSJ
Teva Inks $40.5 Billion Deal to Acquire Allergan's Generics Unit - Legal Reader
Teva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook Warning - WSJ
Calaméo - Wallstreetjournal 20170810 The Wall Street Journal
Calaméo - Wallstreetjournal 20170811 The Wall Street Journal
Teva's sunny forecast for crucial migraine drug Ajovy raises eyebrows on Wall Street | Fierce Pharma
Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week